Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-14

Clinical Trial Update: Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Rizatriptan (5 mg and 10 mg), Sumatriptan (100 mg), and Placebo for migraine; completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan (Rizatriptan)
  • Sumatriptan (Sumatriptan)

Snippet

Sponsor: Organon and Co | Conditions: Migraine Headache | Phase 3 | Status: COMPLETED | Results posted: 2009-07-14